Our point of view. Trough to peak ratio of antihypertensive drugs: methodologic issues and clinical implications
Polónia, J.
Revista Portuguesa de Cardiologia Orgao Oficial da Sociedade Portuguesa de Cardiologia 15(4): 281-292
1996
ISSN/ISBN: 0870-2551 PMID: 8814671 Document Number: 461060
Document emailed within 1 workday
Related Documents
Mancia, G.; Salvetti, A. 1994: The trough-to-peak ratio in the evaluation of an antihypertensive drug Giornale Italiano di Cardiologia 24(8): 1043-1048Omboni; Parati; Mancia 1998: The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension Blood Pressure Monitoring 3(3): 201-204
Zanchetti, A. 1994: Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. Italian Nifedipine GITS Study Group Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(8): S97-106
Matsushita, K. 2017: Current Condition and Issues of Clinical Biobanks in Japan -From the Point of View of Laboratory Medicine- Rinsho Byori. Japanese Journal of Clinical Pathology 65(2): 181-189
Pfisterer, M. 1991: Negative inotropic effects of antiarrhythmic drugs: a clinical point of view Journal of Cardiovascular Pharmacology 17(Suppl 6): S44-S47
Horsmans-Pijls, M. 1976: What can be done to strengthen the attraction of the countryside from the point of view of economics, communication and culture and improve the quality of life in rural areas? A. from the point of view of farm women Publications de la CEA: 5 88-91
Taube, C.; Block, H.U.; Förster, W. 1982: Antihypertensive drugs alter the production and the ratio of prostaglandins e and F in the organs of spontaneously hypertensive rats Acta Biologica et Medica Germanica 41(5): 477-485
Chalmers, A.; Lee, P. 1988: Monitoring of nonsteroidal antiinflammatory drugs in populations. a clinician's point of view Journal of Rheumatology. Suppl 17: 3-4
Uchida, E. 1999: An evaluation of non-clinical animal data from the point of view of a clinical pharmacologist Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 113(1): 47-53
Forcier, J.I.; Kight, M.A.; Sheehan, E.T. 1977: Point of view: acculturation in clinical dietetics Journal of the American Dietetic Association 70(2): 181-185
Chopra, A. 1991: Lysine acetylsalicylate: a clinical view point Journal of the Association of Physicians of India 39(9): 729
Beck, A.; Stöger, H. 1976: Maternal mortality in Austria from a clinical point of view Wiener Klinische Wochenschrift 88(10): 309-315
Alday Redonnet, T. 1961: Critical and comparative study, from the pharmacological point of view, of the 16th Revised Edition of the United States Pharmacopoeia. I. Selection of the monographic chapters in which are described the drugs Farmacognosia; Anales del Instituto Jose Celestino Mutis 21: 257-292
Levizzani, G. 2001: Drugs and nutritional supplements in sports: use and abuse. The sports physician's point of view Minerva Pediatrica 53(5): 409
Sajnerová, B.; Kejrová, D. 1976: A comment on paucibacillary findings in pulmonary TB from the clinical point of view Casopis Lekaru Ceskych 115(17): 505-507
Jenicek, M.; Berraondo, I. 1985: Epidemic toxic syndrome. Evaluation from the point of view of clinical epidemiology Revista Clinica Espanola 177(3): 99-103
Macgregor, A.G. 1970: Personal point of view--clinical pharmacology and modern medical practice Health Bulletin 28(3): 69-71
Schneider, G.; Bürger, K.; Schimmelpfennig, W.; Wagner, L.; Zimmermann, H.B. 1976: Clinical aspects and therapy of portal hypertension from the view point of the internist Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 36(3-4): 163-164
Jakob, A.; Steinheisser, C. 1971: Clinical contribution to myocardial infarct from the point of view of a regional hospital Das Deutsche Gesundheitswesen 26(25): 1156-1160
Tsubura, E.; Nishikawa, H.; Chikata, E.; Yamashita, T. 1985: Mechanism of cancer metastasis and its inhibition--a point of view from clinical aspects Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(6): 1189-1195